BU-NOT-SET

CONTACT US
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
The potential impact of Brexit on patient safety
  • Industry trends
Eyes
Insight
EU FMD: After the deadline
  • Manufacturing
Eyes
Insight
The importance of supply chain security
  • Manufacturing
Eyes
Insight
ADC development: setbacks and key developments
  • Drug substance
Lab equipment
Insight
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
  • Drug substance
Eyes
Insight
CDMO trends: Drug development and industry consolidation
  • Industry trends
Eyes
Insight
Consolidation in the CDMO Market
  • Industry trends
Eyes
Insight
Fact sheet
  • Analytical chemistry
Nitrosamines analysis
Insight
  • Biologics
  • Drug substance
Enabling oral solid dosage form delivery of biologics
Fact sheet
  • Biologics
Plasmid DNA manufacturing capabilities
Insight
  • Analytical chemistry
  • Drug substance
Leveraging analytics throughout development and manufacture to achieve commercial success
Insight
  • Sustainability
2,300 solar panels installed at Recipharm’s Holmes Chapel
White paper
  • Analytical chemistry
  • Drug substance
Analysing prebiotic oligosaccharides for future product innovation
Insight
  • Industry trends
  • Manufacturing
Enhancing sterile processing for future vaccine programs
Insight
  • Sustainability
Increasing carbon emission transparency through SBTi contributions
Insight
  • Biologics
Single-use technologies are enabling increasing demand for biologics